Peter Jung

4PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.

Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky

|Oct 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis.

Leon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec

|Jun 27, 2020
Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.

Vanessa Dietinger, Cira R García de Durango, Svenja Wiechmann

Pageof 1